Salvador Moncada

151.2k citations
621 papers · 123.8k indexed · 65 hit papers · h-index 161
Co-authors
Richard PalmerE.A. HiggsJohn R. VaneAnthony G. FerrigeMarek W. RadomskiRichard G. KnowlesFranklin H. EpsteinRyszard J. Gryglewski
Topics
Nitric Oxide and Endothelin Effects (286 papers)Eicosanoids and Hypertension Pharmacology (172 papers)Inflammatory mediators and NSAID effects (132 papers)
Cited by
BiochemistryPhysiologyEndocrine and Autonomic Systems
Journals
NatureScienceNew England Journal of Medicine
Partner nations
United KingdomSpainUnited States

In The Last Decade

Salvador Moncada

614 papers receiving 118.2k citations

Hit Papers

Nitric oxide: physiology, pathophysiology, and pharmaco...1971202619892007199119871993198819764.0k8.0k12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric oxide: physiology, pathophysiology, and pharmacology.
    1991 13.5k citations Salvador Moncada, E.A. Higgs et al. profile →
  2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
    1987 8.6k citations Salvador Moncada et al. profile →
  3. The L-Arginine-Nitric Oxide Pathway
    1993 5.5k citations Salvador Moncada et al. profile →
  4. Vascular endothelial cells synthesize nitric oxide from L-arginine
    1988 3.9k citations Salvador Moncada et al. profile →
  5. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
    1976 2.8k citations Salvador Moncada, Ryszard J. Gryglewski et al. profile →
  6. Nitric oxide synthases in mammals
    1994 2.3k citations Salvador Moncada et al. profile →
  7. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
    1986 2.0k citations Ryszard J. Gryglewski, Salvador Moncada et al. profile →
  8. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
    1990 1.7k citations H. F. Hodson, Salvador Moncada et al. British Journal of Pharmacology profile →
  9. Role of endothelium-derived nitric oxide in the regulation of blood pressure.
    1989 1.5k citations Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  10. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN
    1989 1.3k citations Salvador Moncada et al. profile →
  11. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    1978 1.3k citations Salvador Moncada, John R. Vane profile →
  12. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
    1989 1.3k citations Miriam Palacios‐Callender, Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  13. ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
    1987 1.2k citations Salvador Moncada et al. profile →
  14. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
    1988 1.1k citations Salvador Moncada et al. profile →
  15. Altered immune responses in mice lacking inducible nitric oxide synthase
    1995 1.1k citations Salvador Moncada et al. profile →
  16. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide
    1994 1.0k citations Salvador Moncada et al. profile →
  17. Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide
    2003 1.0k citations Enzo Nisoli, Emilio Clementi et al. Science profile →
  18. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
    1990 1.0k citations Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  19. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
    1987 932 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  20. Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
    1979 913 citations Salvador Moncada, John R. Vane profile →
  21. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.
    1990 909 citations Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  22. Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS
    2005 903 citations Enzo Nisoli, Cristina Tonello et al. Science profile →
  23. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
    1976 815 citations Ryszard J. Gryglewski, Salvador Moncada et al. profile →
  24. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
    1976 789 citations Salvador Moncada, John R. Vane et al. profile →
  25. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
    1989 785 citations Salvador Moncada et al. profile →
  26. A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation
    1989 745 citations H. F. Hodson, Salvador Moncada et al. British Journal of Pharmacology profile →
  27. Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
    1971 744 citations Salvador Moncada, John R. Vane et al. profile →
  28. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans
    1991 744 citations Salvador Moncada et al. profile →
  29. Persistent inhibition of cell respiration by nitric oxide: Crucial role ofS-nitrosylation of mitochondrial complex I and protective action of glutathione
    1998 710 citations Emilio Clementi, Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  30. HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
    1977 690 citations Salvador Moncada, E.A. Higgs et al. profile →
  31. The discovery of nitric oxide and its role in vascular biology
    2006 683 citations Salvador Moncada, E.A. Higgs British Journal of Pharmacology profile →
  32. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets
    1987 670 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  33. Roles of nitric oxide in tumor growth.
    1995 664 citations Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  34. Molecular mechanisms and therapeutic strategies related to nitric oxide
    1995 658 citations Salvador Moncada, E.A. Higgs profile →
  35. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1
    2009 647 citations Ángeles Almeida, Salvador Moncada et al. profile →
  36. Does nitric oxide modulate mitochondrial energy generation and apoptosis?
    2002 646 citations Salvador Moncada et al. profile →
  37. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
    1990 631 citations Salvador Moncada et al. profile →
  38. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide
    1992 619 citations Salvador Moncada et al. profile →
  39. Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
    2003 614 citations Thilo Hagen, Francis Lam et al. Science profile →
  40. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
    1987 600 citations Salvador Moncada et al. profile →
  41. The chemical structure of prostaglandin X (prostacyclin)
    1976 599 citations John A. Salmon, Salvador Moncada et al. profile →
  42. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.
    1992 598 citations Salvador Moncada et al. profile →
  43. Endogenous nitric oxide: physiology, pathology and clinical relevance
    1991 597 citations Salvador Moncada, E.A. Higgs profile →
  44. The 1991 Ulf von Euler Lecture:Thel‐arginine: nitric oxide pathway
    1992 575 citations Salvador Moncada profile →
  45. Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases
    1991 562 citations Salvador Moncada et al. profile →
  46. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
    1977 532 citations Salvador Moncada, E.A. Higgs et al. profile →
  47. Nitric oxide synthase activity in human breast cancer
    1995 529 citations Salvador Moncada et al. profile →
  48. Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium
    1992 519 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  49. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
    1977 515 citations J.E. Tateson, Salvador Moncada et al. profile →
  50. INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
    1999 509 citations Salvador Moncada et al. profile →
  51. Hyperdynamic circulation in cirrhosis: a role for nitric oxide?
    1991 496 citations Salvador Moncada et al. profile →
  52. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells
    1989 495 citations Salvador Moncada et al. profile →
  53. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
    1976 491 citations Salvador Moncada, Ryszard J. Gryglewski et al. profile →
  54. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
    1976 425 citations Salvador Moncada, John R. Vane et al. profile →
  55. UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSIS
    1978 348 citations Salvador Moncada, John R. Vane profile →
  56. Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
    1977 339 citations Salvador Moncada, John R. Vane et al. profile →
  57. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
    1980 315 citations Brendan J.R. Whittle, G.A. Higgs et al. profile →
  58. Prostacyclin is a circulating hormone
    1978 292 citations Salvador Moncada, John R. Vane et al. profile →
  59. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
    1978 284 citations Brendan J.R. Whittle, Salvador Moncada et al. profile →
  60. The Third Version of the Copenhagen Psychosocial Questionnaire
    2019 280 citations Salvador Moncada, Clara Llorens et al. profile →
  61. Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
    1973 251 citations Salvador Moncada, John R. Vane et al. profile →
  62. Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs
    1973 249 citations Salvador Moncada, John R. Vane et al. British Journal of Pharmacology profile →
  63. : A selective inhibitor of thromboxane synthetase
    1977 247 citations Salvador Moncada, John R. Vane et al. profile →
  64. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes
    1978 240 citations John A. Salmon, Salvador Moncada et al. profile →
  65. COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS
    1978 222 citations Salvador Moncada, John R. Vane et al. British Journal of Pharmacology profile →

Peers

Salvador Moncada
Comparison fields: 5 of 207
  • Physiology 65.1k
  • Molecular Biology 26.7k
  • Cardiology and Cardiovascular Medicine 26.5k
  • Biochemistry 22.9k
  • Pharmacology 13.4k
Replace Richard Palmer with:
Richard Palmer United Kingdom
Barry Halliwell United Kingdom
John R. Vane United Kingdom
Bruce M. Spiegelman United States
Jonathan S. Stamler United States
Gerald I. Shulman United States
David G. Harrison United States
Bruce Α. Freeman United States
Csaba Szabó United States
Peter J. Barnes United Kingdom
Salvador Moncada relative to Richard Palmer United Kingdom Richard Palmer's profile →
Citations per field
00.5×2×4×5.7×
Richard Palmer · 1×
Citations per year

Countries citing papers authored by Salvador Moncada

Since Specialization
Citations

This map shows the geographic impact of Salvador Moncada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvador Moncada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvador Moncada more than expected).

Fields of papers citing papers by Salvador Moncada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvador Moncada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvador Moncada. The network helps show where Salvador Moncada may publish in the future.

Co-authorship network of co-authors of Salvador Moncada

This figure shows the co-authorship network connecting the top 25 collaborators of Salvador Moncada. A scholar is included among the top collaborators of Salvador Moncada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvador Moncada. Salvador Moncada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Mental health inequalities in times of crisis: evolution between 2005 and 2021 among the Spanish salaried population
2022 ·Journal of Epidemiology & Community Health ·(unknown),Clara Llorens,Jordi Alonso,Gemma Vilagut,Salvador Moncada,Albert Navarro
5
2
Prevalence, associated factors and reasons for sickness presenteeism: a cross-sectional nationally representative study of salaried workers in Spain, 2016
2018 ·BMJ Open ·Albert Navarro,(unknown),Salvador Moncada,Clara Llorens,(unknown)
24
3
Mitochondrial Dynamics, Biogenesis, and Function Are Coordinated with the Cell Cycle by APC/C-CDH1 (Retraction of vol 15, pg 466, 2012)
2012 ·UCL Discovery (University College London) ·Assegid Garedew,Catia Andreassi,Salvador Moncada
5
4
La reforma laboral y su impacto en la salud
2012 ·Joan Benach,(unknown),Carles Muntañer,Salvador Moncada,Clara Llorens
1
5
Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes
2010 ·Proceedings of the National Academy of Sciences ·Sergio L. Colombo,Miriam Palacios‐Callender,Nanci Frakich,(unknown),Christoph Schmitt,(unknown),(unknown),Salvador Moncada
96
6
E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation
2009 ·Proceedings of the National Academy of Sciences ·Ángeles Almeida,Juan P. Bolaños,Salvador Moncada
134
7
Cytochrome c oxidase regulates endogenous nitric oxide availability in respiring cells: A possible explanation for hypoxic vasodilation
2007 ·Proceedings of the National Academy of Sciences ·Miriam Palacios‐Callender,Victoria Hollis,Miriam Mitchison,Nanci Frakich,(unknown),Salvador Moncada
69
8
Nitric oxide and hypoxia. In: Essays in Biochemistry - Oxygen sensing and hypoxia-induced responses.
2007 ·UCL Discovery (University College London) ·Alexander Galkin,E.A. Higgs,Salvador Moncada
2
9
Inhibition of cellular respiration by endogenously produced carbon monoxide
2006 ·Journal of Cell Science ·Gabriela D’Amico,Francis Lam,Thilo Hagen,Salvador Moncada
105
10
Mitochondria as signaling organelles in the vascular endothelium
2006 ·Proceedings of the National Academy of Sciences ·Marisol Quintero,Sergio L. Colombo,Andrew Godfrey,Salvador Moncada
293
11
Mitochondrial biogenesis as a cellular signaling framework (vol 67, pg 1, 2004)
2004 ·UCL Discovery (University College London) ·Enzo Nisoli,Emilio Clementi,Salvador Moncada,(unknown)
0
12
Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxidebreakdown →
2003 ·Science ·Enzo Nisoli,Emilio Clementi,Clara Paolucci,Valeria Cozzi,Cristina Tonello,Clara Sciorati,Renata Bracale,Alessandra Valerio,Maura Francolini,Salvador Moncada,Michele O. Carruba
1011
13
Ocupar cargos de responsabilidad, ¿un factor protector de la salud?*
2000 ·Archivos de Prevención de Riesgos Laborales ·(unknown),(unknown),Salvador Moncada,(unknown),Imma Cortès
2
14
Non-adrenergic non-cholinergic responses in the rabbit vaginal wall are mediated by nitrergic neurotransmission
1999 ·UCL Discovery (University College London) ·Selim Cellek,(unknown),Salvador Moncada
2
15
Endothelium-derived nitric oxide
1999 ·UCL Discovery (University College London) ·Salvador Moncada
14
16
La salud de los trabajadores y del sistema sanitario. A propósito de los cambios en la gestión de la incapacidad temporal para el trabajo
1999 ·Archivos de Prevención de Riesgos Laborales ·Salvador Moncada,(unknown),(unknown)
0
17
Regulation of gall bladder motility by the arginine-nitric oxide pathway in guinea pigs.
1993 ·Gut ·M Mourelle,Francisco Guarner,Xavier Molero,Salvador Moncada,J. R. Malagelada
41
18
Enzymology, biochemistry and immunology
1992 ·Salvador Moncada
9
19
The Effects of a Novel Series of Selective Inhibitors of Arachidonate 5‐Lipoxygenase on Anaphylactic and Inflammatory Responses
1988 ·Annals of the New York Academy of Sciences ·P. Bhattacherjee,N. K. Boughton-Smith,R.L. Follenfant,L.G. Garland,G.A. Higgs,H. F. Hodson,(unknown),W. P. U. Jackson,Salvador Moncada,Adrian N. Payne,Roger Randall,Charles H. Reynolds,John A. Salmon,J.E. Tateson,Brendan J.R. Whittle
27
20
PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY
1971 ·British Journal of Pharmacology ·Robert Walker,G.N. Woodruff,A. W. Cuthbert,P.Y.D. Wong,Sónia Ferreira,Salvador Moncada,Ryszard J. Gryglewski,John R. Vane,James McCormick,J. Senior,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)
6

About Salvador Moncada

Salvador Moncada is a scholar working on Biochemistry, Physiology and Pharmacology, having authored 621 papers that have together received 123.8k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (286 papers), Eicosanoids and Hypertension Pharmacology (172 papers) and Inflammatory mediators and NSAID effects (132 papers). The work is most often cited by research in Biochemistry (22.9k citations), Physiology (65.1k citations) and Endocrine and Autonomic Systems (9.6k citations). Salvador Moncada has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Richard Palmer, E.A. Higgs, John R. Vane, Anthony G. Ferrige, Marek W. Radomski, Richard G. Knowles, Franklin H. Epstein, Ryszard J. Gryglewski, Daryl D. Rees and D. Ashton. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard PalmerBreakdown of academic impact, for papers by Barry HalliwellBreakdown of academic impact, for papers by John R. VaneBreakdown of academic impact, for papers by Bruce M. SpiegelmanBreakdown of academic impact, for papers by Jonathan S. StamlerBreakdown of academic impact, for papers by Gerald I. ShulmanBreakdown of academic impact, for papers by David G. HarrisonBreakdown of academic impact, for papers by Bruce Α. FreemanBreakdown of academic impact, for papers by Csaba SzabóBreakdown of academic impact, for papers by Peter J. Barnes
Rankless by CCL
2026